Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Uscom Limited ( (AU:UCM) ) has issued an update.
Uscom Limited has announced an agreement to sell its entire business and assets to AXO Medtech VCC, a Singapore-based investment company, subject to shareholder approval. This strategic move aims to address Uscom’s financial difficulties and enable the business to raise necessary capital for transformation into a profitable entity. The sale includes all shares in its subsidiary, UCM SNG, for $2.591 million, which will be settled by transferring existing liabilities. AXO plans to continue Uscom’s operations, retain employees, and raise capital to expedite global expansion. The transaction is expected to be completed by late November 2025, pending shareholder approval.
More about Uscom Limited
Uscom Limited is a company operating in the medical technology industry, focusing on developing and enhancing its products for global operations. The company has faced financial challenges, including losses and negative cash flow, which have hindered its ability to build inventory and develop its business.
Average Trading Volume: 178,515
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.12M
See more data about UCM stock on TipRanks’ Stock Analysis page.